Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

The data docket for the coming week is light, leaving the focus squarely on tariffs - so far, the U.S. administration has a ...

If you do a deep dive, you might end up with one of these unstoppable stocks in your portfolio today. Reuben Gregg Brewer has ...

Valued at roughly $47.4 billion by market cap, L3Harris Technologies, Inc. (LHX) is reshaping the defense landscape with ...